Skip to content
terbogrel

Structure via PubChem · Public domain (PubChem)

EntityQ7701660· pop 5· linked from 313 articles

Terbogrel (INN) is an experimental drug that has been studied for its potential to prevent the vasoconstricting and platelet-aggregating action of thromboxanes. Terbogrel is an orally available thromboxane A2 receptor antagonist and a thromboxane A synthase inhibitor. The drug was developed by Boehringer Ingelheim.

Chemical data

Formula
C23H27N5O2
Molecular weight
405.5 g/mol
IUPAC name
(E)-6-[3-[(N'-tert-butyl-N-cyanocarbamimidoyl)amino]phenyl]-6-pyridin-3-ylhex-5-enoic acid
SMILES
CC(C)(C)N=C(NC#N)NC1=CC=CC(=C1)/C(=C\CCCC(=O)O)/C2=CN=CC=C2
InChIKey
XUTLOCQNGLJNSA-RGVLZGJSSA-N
XLogP
4.2
Polar surface area
110 Ų
H-bond donors
3
H-bond acceptors
5
Formal charge
0

via PubChem

Drug data · ChEMBL

Max clinical phase
Phase 2
Molecule type
Small molecule
Indications
pulmonary arterial hypertension

via ChEMBL · EBI

Wikidata facts

Mass
405.216
Show 4 more facts
chemical formula
C₂₃H₂₇N₅O₂
isomeric SMILES
CC(C)(C)N=C(NC#N)NC1=CC=CC(=C1)/C(=C\CCCC(=O)O)/C2=CN=CC=C2
canonical SMILES
CC(C)(C)N=C(NC#N)NC1=CC=CC(=C1)C(=CCCCC(=O)O)C2=CN=CC=C2
Commons category
Terbogrel
Sources (2)

via Wikidata · CC0

~1 min read

Encyclopedic overview

2 sections
Contents
  • See also
  • References

{{chembox | Verifiedfields = changed | Watchedfields = changed | verifiedrevid = 470602217 | ImageFile = Terbogrel.svg | ImageSize = | IUPACName = (5E)-6-{3-[tert-Butyl(cyano)carbamimidamido]phenyl}-6-pyridin-3-ylhex-5-enoic acid | OtherNames = (5E)-6-[m-(3-tert-Butyl-2-cyanoguanidino)phenyl]-6-(3-pyridyl)-5-hexenoic acid | Section1 = | Section2 = | Section3 = }}

Terbogrel (INN) is an experimental drug that has been studied for its potential to prevent the vasoconstricting and platelet-aggregating action of thromboxanes. Terbogrel is an orally available thromboxane A2 receptor antagonist and a thromboxane A synthase inhibitor. The drug was developed by Boehringer Ingelheim.

Excerpted from Wikipedia’s “terbogrel” article, available under the CC BY-SA 4.0 licence.

Available in 4 languages

via Wikidata sitelinks · CC0